Pubdate: Mon, 12 Jan 2009
Source: Dominion Post, The (New Zealand)
Contact:  2009 The Dominion Post
Website: http://www.dompost.co.nz
Details: http://www.mapinc.org/media/2550
Author: Anna Chalmers
Bookmark: http://mapinc.org/topic/BZP
Bookmark: http://mapinc.org/topic/DMAA

NEW PARTY PILLS LEAVE FOUR SERIOUSLY ILL

Health officials want one of the main ingredients in new-generation 
party pills restricted after four users became seriously ill.

Advice to the Government highlights concerns about DMAA 
(dimethylamylamine), a derivative of geranium oil, which is a 
"psychoactive substance" that reportedly gives users an adrenaline rush.

DMAA is included in several new-generation party pill substances, 
including Sunrise and Hummer.

These flooded the market when BZP varieties were banned and were now 
being sold nationally in stores, including dairies, without age restrictions.

Papers released under the Official Information Act showed a 
45-year-old man suffered a stroke after taking DMAA in powder form, 
and other users had been hospitalised with severe nausea and 
headaches. The industry estimates 100,000 DMAA-based party pills have 
been sold since the banning of BZP in April.

A Health Ministry report to the Government's expert drug committee 
responsible for classifying drugs said while the hospital admissions 
were believed to be due to DMAA use, there was not enough evidence to 
ban the substance.

"[But] the ministry believes the regulation of DMAA as a restricted 
substance would be a preferable course of action to the status quo, 
which offers no controls around the marketing and availability of the 
substance."

It follows calls by drug experts last week to also make "chemical 
cannabis" marketed as Spice or Dream a restricted substance.

The restricted-substance classification was introduced in November.

It gives authorities greater control over the sale and marketing of a 
substance, including age restrictions.

Emergency department heads blew the whistle on DMAA after a spike in 
users admitted to Wellington and Waikato hospitals following the ban 
on BZP pills. Four serious cases at Waikato Hospital in June and July 
prompted the Health Ministry to issue a voluntary suspension of its 
sale in powder form in October.

A report to the committee in November said because only powdered DMAA 
was recalled, pills containing the substance were "still widely available".

The Expert Advisory Committee on Drugs could not be contacted.

However, Drug Foundation director Ross Bell said DMAA should be 
classified as a restricted substance "as soon as possible".

He said the effects of DMAA were unknown.

Classification would mean the product could be sold with health 
warnings, but children could not legally buy it.

Matt Bowden, founder of party-pill developer Stargate International, 
would welcome DMAA restrictions.

Problems were being encountered because there were no restrictions on 
the quantity used in pills, he said.

WHAT IS DMAA?

DMAA, or dimethylamylamine, is a stimulant derived from geranium 
plant oil and is usually mixed with other substances, including 
caffeine, to make party pills. It acts on the central nervous system, 
giving a rush similar to adrenaline. It is believed DMAA was first 
synthesised in the 1940s as a nasal decongestant and is also found in 
dietary and body-building products. The Health Ministry says the 
composition of the substance cannot be verified as there is no 
international research. While most users take DMAA orally, at least 
one hospital admission was linked to the substance being injected.
- ---
MAP posted-by: Jay Bergstrom